Literature DB >> 22739041

Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.

Zu-Yau Lin1, Yen-Hwang Chuang, Wan-Long Chuang.   

Abstract

Impact of different cancer-associated fibroblast (CAF) cell lines on proliferation, migration, invasion and differential expressions of genes in different hepatocellular carcinoma (HCC) cell lines was investigated. Two human CAF cell lines (F26/KMUH, F28/KMUH) and two human HCC cell lines (HCC24/KMUH, HCC38/KMUH) were studied. Influence of F28/KMUH cells on expressions of genes in HCC38/KMUH cells was detected by microarray to select genes for further analysis. Both CAF cell lines promoted proliferation (all P<0.05), migration (all P<0.05) and Matrigel invasion (all P<0.0001) of both HCC cell lines. F26/KMUH cells showed stronger promoted effects on, firstly, proliferation of HCC24/KMUH cells (P=0.0064) and, secondly, migration of both HCC cell lines than F28/KMUH cells did (all P<0.002). Ten up-regulated genes (APLN, CCL2, CCL26, CXCR4, IL6, MUC1, LOXL2, PDGFA, PGK1, VEGFA) related to proliferation, migration, invasion and angiogenesis of HCC detected by microarray were selected for quantitative reverse transcriptase-polymerase chain reaction analysis. Both CAF cell lines had same tendency of effects on differential expressions of genes in same HCC cell line, but expressions of genes between different HCC cell lines were not consistent. Only CCL2, CCL26, IL6 and LOXL2 genes were consistently up-regulated in both HCC cell lines. In conclusion, the effects of CAFs to promote proliferation, migration and invasion of HCC cells are influenced by the characteristics of both CAFs and HCC cells. Up-regulations of CCL2, CCL26, IL6 and LOXL2 genes in cancer cells are part of the common effects of CAFs on HCC cells.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739041     DOI: 10.1016/j.biopha.2012.02.001

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  28 in total

Review 1.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

2.  Orthotopic non-metastatic and metastatic oral cancer mouse models.

Authors:  Manish V Bais; Maria Kukuruzinska; Philip C Trackman
Journal:  Oral Oncol       Date:  2015-02-11       Impact factor: 5.337

Review 3.  Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma - a Review.

Authors:  Irmak Ayvaz; Dilara Sunay; Ece Sariyar; Esra Erdal; Zeynep Firtina Karagonlar
Journal:  J Gastrointest Cancer       Date:  2021-12-20

Review 4.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  C19MC microRNAs regulate the migration of human trophoblasts.

Authors:  Lan Xie; Jean-Francois Mouillet; Tianjiao Chu; W Tony Parks; Elena Sadovsky; Martin Knöfler; Yoel Sadovsky
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

6.  Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.

Authors:  Quanchi Chen; Wei Sun; Yuxin Liao; Hui Zeng; Liancheng Shan; Fei Yin; Zhuoying Wang; Zifei Zhou; Yingqi Hua; Zhengdong Cai
Journal:  Mol Med Rep       Date:  2015-02-18       Impact factor: 2.952

Review 7.  Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Authors:  Fuming Zi; Jingsong He; Donghua He; Yi Li; Li Yang; Zhen Cai
Journal:  Mol Med Rep       Date:  2015-01-14       Impact factor: 2.952

8.  Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.

Authors:  Jhih-Ying Chi; Yu-Wei Hsiao; Chien-Feng Li; Yu-Chih Lo; Zu-Yau Lin; Jhen-Yi Hong; Yang-Ming Liu; Xiu Han; Shao-Ming Wang; Ben-Kuen Chen; Kelvin K Tsai; Ju-Ming Wang
Journal:  Oncotarget       Date:  2015-09-15

9.  Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma.

Authors:  Christoph Roderburg; Sven H Loosen; Jan Bednarsch; Patrick H Alizai; Anjali A Roeth; Sophia M Schmitz; Mihael Vucur; Mark Luedde; Pia Paffenholz; Frank Tacke; Christian Trautwein; Tom F Ulmer; Ulf Peter Neumann; Tom Luedde
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

10.  Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.

Authors:  Who-Whong Wang; Soo Fan Ang; Rajneesh Kumar; Charmain Heah; Andi Utama; Navessa Padma Tania; Huihua Li; Sze Huey Tan; Desmond Poo; Su Pin Choo; Wan Cheng Chow; Chee Kiat Tan; Han Chong Toh
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.